| 摘要 |
Use of an alpha -interferon composition in the manufacture of a medicament for reducing the recurrence of a resectable malignant tumor is described. Use of an alpha -interferon composition in the manufacture of a medicament for treating a human patient having a non-resectable malignant tumor also is described. An article of manufacture combines an alpha -interferon composition within a packaging material and a package label or insert indicating that administration of an immunostimulatory dosage of an alpha -interferon composition followed by surgical resection of a malignant tumor can be effective for treating a human patient having the malignant tumor.
|
